Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to evaluate whether a reduction in the heparin dose from 140 to 100
U/kg is associated with a better net clinical outcome in patients undergoing PCI after
pretreatment with 600mg clopidogrel